NEXUS BIOPHARMA INC
CIK 0001424151
Revenue (TTM)
—
Q1 Oct 2017
Net Income (TTM)
−$967.11K
+40.5% YoY
Q1 Oct 2017
EPS Diluted (TTM)
—
Q1 Oct 2017
Gross Margin
—
Q1 Oct 2017
Operating Margin
—
Q1 Oct 2017
Net Margin
—
Q1 Oct 2017
Free Cash Flow (TTM)
—
Q1 Oct 2017
Cash
$8.43K
Q1 Oct 2017
Total Debt
—
Q1 Oct 2017
Shares Outstanding
64.3M sh
Q1 Oct 2017
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.